- Home
- FLS vs ITCI Comparison
FLS vs ITCI Comparison
Compare FLS & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLS
- ITCI
- Stock Information
- Founded
- FLS 1790
- ITCI 2002
- Country
- FLS United States
- ITCI United States
- Employees
- FLS N/A
- ITCI N/A
- Industry
- FLS Fluid Controls
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- FLS Industrials
- ITCI Health Care
- Exchange
- FLS Nasdaq
- ITCI Nasdaq
- Market Cap
- FLS 7.9B
- ITCI 8.0B
- IPO Year
- FLS N/A
- ITCI N/A
- Fundamental
- Price
- FLS $59.24
- ITCI $83.42
- Analyst Decision
- FLS Buy
- ITCI Strong Buy
- Analyst Count
- FLS 10
- ITCI 12
- Target Price
- FLS $60.10
- ITCI $97.67
- AVG Volume (30 Days)
- FLS 1.3M
- ITCI 733.0K
- Earning Date
- FLS 10-28-2024
- ITCI 10-30-2024
- Dividend Yield
- FLS 1.42%
- ITCI N/A
- EPS Growth
- FLS 8.69
- ITCI N/A
- EPS
- FLS 2.03
- ITCI N/A
- Revenue
- FLS $4,542,636,000.00
- ITCI $613,728,000.00
- Revenue This Year
- FLS $7.14
- ITCI $48.25
- Revenue Next Year
- FLS $7.34
- ITCI $38.47
- P/E Ratio
- FLS $29.18
- ITCI N/A
- Revenue Growth
- FLS 8.30
- ITCI 46.08
- 52 Week Low
- FLS $37.24
- ITCI $54.17
- 52 Week High
- FLS $61.61
- ITCI $93.45
- Technical
- Relative Strength Index (RSI)
- FLS 64.13
- ITCI 50.72
- Support Level
- FLS $58.52
- ITCI $89.28
- Resistance Level
- FLS $61.61
- ITCI $93.45
- Average True Range (ATR)
- FLS 1.46
- ITCI 3.23
- MACD
- FLS 0.30
- ITCI -0.27
- Stochastic Oscillator
- FLS 78.90
- ITCI 43.90
About FLS Flowserve Corporation
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. In addition, Flowserve has a network of Quick Response Centers to provide aftermarket equipment services. The aftermarket services help customers with installation, diagnostics, repair, and retrofitting. Sales are roughly split across many regions, with North America and Europe contributing the majority of total revenue.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.